Oxidative phosphorylation modulator (study drug)

· Neukidney Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oxidative phosphorylation modulator (study drug), covering 2025-09-08 to 2025-09-08. Get the full timeline:

Most recent: Clinical Trial Update: Outcome of Use of a Novel Modulator of Oxidative Phosphorylation on Kidney Function in Patients With Progressive Chronic Kidney Disease

See pricing